KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Common Equity (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Common Equity for 9 consecutive years, with $6.5 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 7.4% to $6.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.5 billion through Dec 2025, up 7.4% year-over-year, with the annual reading at $6.5 billion for FY2025, 7.4% up from the prior year.
  • Common Equity hit $6.5 billion in Q4 2025 for Elanco Animal Health, down from $6.7 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $8.0 billion in Q1 2021 to a low of $5.9 billion in Q2 2024.
  • Historically, Common Equity has averaged $6.9 billion across 5 years, with a median of $6.8 billion in 2025.
  • Biggest five-year swings in Common Equity: increased 20.21% in 2021 and later fell 19.92% in 2024.
  • Year by year, Common Equity stood at $7.5 billion in 2021, then decreased by 2.92% to $7.3 billion in 2022, then fell by 14.62% to $6.2 billion in 2023, then fell by 2.04% to $6.1 billion in 2024, then increased by 7.4% to $6.5 billion in 2025.
  • Business Quant data shows Common Equity for ELAN at $6.5 billion in Q4 2025, $6.7 billion in Q3 2025, and $6.8 billion in Q2 2025.